Lilly Lowers 2019 Forecast Due To Drug Failure, Pending Deal
Shares of Eli Lilly slipped in early trading Wednesday after the drugmaker announced fourth-quarter earnings that missed Wall Street expectations and dropped its forecast for 2019.
Shares of Eli Lilly slipped in early trading Wednesday after the drugmaker announced fourth-quarter earnings that missed Wall Street expectations and dropped its forecast for 2019.